一项评估液基子宫内膜细胞学检查与经阴道超声作为子宫内膜癌筛查工具的研究:570例绝经后女性
研究纳入570例因异常出血或其他症状和/或超声子宫内膜厚度超过5 mm的绝经后患者,均行经阴道超声、子宫内膜细胞学检查、宫腔镜及诊刮。以诊刮组织学为参考,细胞学诊断非典型增生或更严重病变的敏感度80.7%、特异度94.7%,超声分别为86.8%、20.4%。作者认为两者可能作为绝经后女性子宫内膜病变检测的有效一线方法。
要点
- 子宫内膜细胞学诊断非典型增生或更严重病变的敏感度80.7%、特异度94.7%。
- 经阴道超声诊断非典型增生或更严重病变的敏感度86.8%、特异度20.4%。
- 细胞学或超声任一阳性联合诊断的敏感度97.4%,但特异度仅17.5%。
核心结论
- 经阴道超声和子宫内膜细胞学检查可能被视为绝经后女性子宫内膜病理检测的有效一线方法。
研究设计与样本
- 研究纳入570例因异常出血或其他症状和/或超声子宫内膜厚度超过5 mm的绝经后患者,均行经阴道超声、子宫内膜细胞学检查、宫腔镜及诊刮,以诊刮组织学为参考标准,采用WHO分类诊断。
诊断标准与关键数值
- 子宫内膜细胞学诊断非典型增生或更严重病变的敏感度80.7%、特异度94.7%、阳性预测值58.2%、阴性预测值94.4%、准确率84.6%。
- 经阴道超声诊断非典型增生或更严重病变的敏感度86.8%、特异度20.4%、阳性预测值21.1%、阴性预测值86.1%、准确率33.7%。
- 细胞学或超声任一阳性诊断非典型增生或更严重病变的敏感度97.4%、特异度17.5%、阳性预测值22.8%、阴性预测值96.4%、准确率33.5%。
- 细胞学和超声均阳性诊断非典型增生或更严重病变的敏感度70.2%、特异度88.4%、阳性预测值60.2%、阴性预测值92.2%、准确率84.7%。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: To evaluate the combination of transvaginal ultrasonography (TVS) and endometrial cytology test (ECT) as a potential diagnostic strategy for endometrial cancer and endometrial precancerous lesions in postmenopausal patients.
METHODS: 570 postmenopausal patients admitted in our hospital due to abnormal bleeding or other symptoms and/or with endometrium thickness over 5 mm on ultrasound. The endometrial thickness was evaluated by TVS. Following obtainment with written consent, all patients underwent ECT, hysteroscopy and then dilatation and curettage (D&C). Cytological sampling was conducted by scratching the uterus cavity using SAP-1 and the samples were prepared as liquid-based smear using SurePath technology. The samples were stained using Papanicolaou method. The correlation between cytological diagnosis and TVS results with the D&C histological diagnosis was analyzed. The WHO classification was used for diagnosis.
RESULTS: Sensitivity of ECT, TVS, ECT or TVS positive, ECT and TVS positive to diagnose atypical hyperplasia or worse were estimated at 80.7%, 86.8%, 97.4%, 70.2%, specificity at 94.7%, 20.4%, 17.5%, 88.4%, positive predictive value at 58.2%, 21.1%, 22.8%, 60.2%, negative predictive value at 94.4%, 86.1%, 96.4%, 92.2%, and accuracy at 84.6%, 33.7%, 33.5%, 84.7%, respectively.
CONCLUSIONS: Transvaginal ultrasonography and Endometrial cytology test may be regarded as a effective first-line method in endometrial pathology detection in postmenopausal women.
引用
- Yang X, Ma K, Chen R, et al. A study evaluating liquid-based endometrial cytology test and transvaginal ultrasonography as a screening tool for endometrial cancer in 570 postmenopausal women. J Gynecol Obstet Hum Reprod. 2023. PMID: 37558050. doi:10.1016/j.jogoh.2023.102643
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。